According to Sun Pharmaceutical
's latest financial reports the company has $1.89 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $1.93 B | 16.1% |
2022-03-31 | $1.66 B | 28.17% |
2021-03-31 | $1.30 B | -10.26% |
2020-03-31 | $1.45 B | -9.92% |
2019-03-31 | $1.61 B | -24.8% |
2018-03-31 | $2.14 B | -9.6% |
2017-03-31 | $2.36 B | 13.3% |
2016-03-31 | $2.09 B | -0.41% |
2015-03-31 | $2.09 B | 31.05% |
2014-03-31 | $1.60 B | 62.15% |
2013-03-31 | $0.98 B | 0.72% |
2012-03-31 | $0.98 B | 7.06% |
2011-03-31 | $0.91 B | 706.81% |
2010-03-31 | $0.11 B | -65.44% |
2009-03-31 | $0.32 B | 5.82% |
2008-03-31 | $0.31 B | -2.85% |
2007-03-31 | $0.31 B | -7.11% |
2006-03-31 | $0.34 B | 27.09% |
2005-03-31 | $0.27 B | 1141.05% |
2004-03-31 | $21.81 M |